Neidio i'r cynnwys

heparin

Ni chefnogir cynnwys y dudalen mewn ieithoedd eraill.

medication which is used as an anticoagulant (blood thinner)

Adnoddau allanol

Rhif Cofrestru CAS
dynodwr MeSH
D006493

enwyd fel: Heparin

dynodwr Encyclopædia Britannica Online
science/heparin

enwyd fel: heparin

ChEMBL ID
Gran Enciclopèdia Catalana ID
dynodwr HMDB
Römpp online ID
WordNet 3.1 Synset ID
03520118-n[5]
dynodwr JSTOR (pwnc)
AICS Chemical ID (BEING DELETED)
PatientsLikeMe treatment ID
ECHA Substance Infocard ID
ID NALT
National Library of Israel J9U ID
dynodwr Freebase
dynodwr Microsoft Academic
dynodwr LCAuth
sh85060283[9]

enwyd fel: Heparin

PubChem CID
UniChem compound ID
dynodwr Quora
dynodwr KEGG
OpenAlex ID
Dynodwr Drugbank (Alberta)
Elhuyar ZTH ID
WikiProjectMed ID
CosIng number
UNII
MedlinePlus drug identifier
ChEBI ID
IEDB Epitope ID
Foundational Model of Anatomy ID
82839[16]

enwyd fel: Heparin

Cod yr ATC
Den Store Danske ID
EC number
232-681-7[17]
dynodwr Llyfrgell Genedlaethol Latfia
dynodwr NDL
dynodwr Gran Enciclopèdia Catalana
WikiSkripta article ID
dynodwr BnF
11965281p[9]

enwyd fel: Héparines

Great Russian Encyclopedia Online ID (old version)
ChemSpider ID
dynodwr yn thesawrws y BNCF
dynodwr Llawlyfr Ffarmacoleg Ligand
dynodwr NKC
ph1144691[19]

enwyd fel: heparin

World Health Organisation international non-proprietary name numeric ID
Brockhaus Enzyklopädie online ID
Cod MeSH
RxNorm ID
DSSTox substance ID

enghraifft o'r canlynol

cyffur hanfodol
grwp neu ddosbarth o sylweddau cemegol

isddosbarth o'r canlynol

anticoagulant
heparins

rhan o'r canlynol

response to heparin[21]

rôl y pwnc: reactant

cellular response to heparin[21]

rôl y pwnc: reactant

adeiledd gemegol

màs

1,039.9 uned Dalton[22]

fformwla gemegol

C₂₆H₄₁NO₃₄S₄[22]

World Health Organisation international non-proprietary name

heparin sodium[23]

clefyd a drinir

emboledd ysgyfeiniol[24]

cadarnhawyd gan: Food and Drug Administration

dyddiad neu amser cychwyn: 21 Mawrth 1972

significant drug interaction

enoxaparin[25]

side effect: retroperitoneal hemorrhage

dalteparin[25]

side effect: retroperitoneal hemorrhage

warffarin[26]

side effect: retroperitoneal hemorrhage

urokinase[25]

side effect: retroperitoneal hemorrhage

alteplase[25]

side effect: retroperitoneal hemorrhage

tenecteplase[25]

side effect: retroperitoneal hemorrhage

Streptokinase[25]

side effect: retroperitoneal hemorrhage

rivaroxaban[25]

side effect: retroperitoneal hemorrhage

apixaban[26]

side effect: retroperitoneal hemorrhage

aspirin[25]

side effect: retroperitoneal hemorrhage

nabwmeton[25]

side effect: retroperitoneal hemorrhage

naprocsen[25]

side effect: retroperitoneal hemorrhage

celecocsib[25]

side effect: retroperitoneal hemorrhage

dicloffenac[25]

side effect: retroperitoneal hemorrhage

pirocsicam[25]

side effect: retroperitoneal hemorrhage

melocsicam[25]

side effect: retroperitoneal hemorrhage

ffenoproffen[25]

side effect: retroperitoneal hemorrhage

fflwrbiproffen[25]

side effect: retroperitoneal hemorrhage

ibwproffen[25]

side effect: retroperitoneal hemorrhage

indometacin[25]

side effect: retroperitoneal hemorrhage

cetoproffen[25]

side effect: retroperitoneal hemorrhage

etodolac[25]

side effect: retroperitoneal hemorrhage

swlindac[25]

side effect: retroperitoneal hemorrhage

clopidogrel[25]

side effect: retroperitoneal hemorrhage

eptiffibatid[25]

side effect: retroperitoneal hemorrhage

iloprost[25]

side effect: retroperitoneal hemorrhage

prostacyclin[25]

side effect: retroperitoneal hemorrhage

parecoxib[25]

side effect: retroperitoneal hemorrhage

tiroffiban[25]

side effect: retroperitoneal hemorrhage

aceclofenac[25]

side effect: retroperitoneal hemorrhage

tenoxicam[25]

side effect: retroperitoneal hemorrhage

prasugrel[25]

side effect: retroperitoneal hemorrhage

ticagrelor[25]

side effect: retroperitoneal hemorrhage

cangrelor[25]

side effect: retroperitoneal hemorrhage

abcicsimab[25]

side effect: retroperitoneal hemorrhage

perindopril[25]

side effect: hyperkalemia

nabwmeton[25]

side effect: hyperkalemia

naprocsen[25]

side effect: hyperkalemia

celecocsib[25]

side effect: hyperkalemia

dicloffenac[25]

side effect: hyperkalemia

pirocsicam[25]

side effect: hyperkalemia

melocsicam[25]

side effect: hyperkalemia

ffenoproffen[25]

side effect: hyperkalemia

fflwrbiproffen[25]

side effect: hyperkalemia

ibwproffen[25]

side effect: hyperkalemia

indometacin[25]

side effect: hyperkalemia

cetoproffen[25]

side effect: hyperkalemia

etodolac[25]

side effect: hyperkalemia

swlindac[25]

side effect: hyperkalemia

enoxaparin[25]

side effect: hyperkalemia

dalteparin[25]

side effect: hyperkalemia

parecoxib[25]

side effect: hyperkalemia

aceclofenac[25]

side effect: hyperkalemia

tenoxicam[25]

side effect: hyperkalemia

dull gweini

subcutaneous injection
intravenous injection

categori beichiogrwydd

categori beichiogrwydd Awstralia C

disgrifiwyd gan y ffynhonnell

Armenian Soviet Encyclopedia, vol. 6

tudalen: 355

categori Comin

Heparins

prif gategori

Category:Heparins

Cyfeiriadau

  1. 1.0 1.1 1.2 1.3 1.4 1.5 DrugBank
  2. SciFinder
  3. DrugBank, Saesneg, 17 Tachwedd 2015, 06779, Dalteparin
  4. IUPHAR/BPS Guide to PHARMACOLOGY, 8 Chwefror 2021
  5. GF WordNet
  6. http://echa.europa.eu/de/information-on-chemicals/registered-substances
  7. Llyfrgell Genedlaethol Israel
  8. Freebase Data Dumps, 28 Hydref 2013
  9. 9.0 9.1 Nuovo soggettario, https://thes.bncf.firenze.sbn.it/termine.php?id=2979, 13 Mehefin 2021
  10. UniChem
  11. Quora
  12. 12.0 12.1 OpenAlex, 26 Ionawr 2022, https://docs.openalex.org/download-snapshot/snapshot-data-format
  13. CosIng database, 28 Rhagfyr 2019, 34248, HEPARIN, CAS no.: 9005-49-6
  14. ChEBI release 2019-10-02
  15. Immune Epitope Database and Analysis Resource, 1 Mawrth 2022, 131188
  16. Foundational Model of Anatomy, 1 Awst 2019
  17. ECHA Substance Infocard database, 27 Rhagfyr 2018, 100.029.698, Heparin, CAS no.: 9005-49-6
  18. National Central Library of Florence
  19. ph1144691, 22 Mawrth 2022, Národní autority České republiky
  20. https://mednet-communities.net/inn/db/ViewINN.aspx?i=392
  21. 21.0 21.1 Gene Ontology release 2019-11-16
  22. 22.0 22.1 PubChem, 23 Medi 2021, 22833565
  23. Recommended INN: List 26, 1986
  24. Inxight: Drugs Database, 2 Tachwedd 2018, https://drugs.ncats.io/drug/T2410KM04A, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/017037s178lbl.pdf
  25. 25.00 25.01 25.02 25.03 25.04 25.05 25.06 25.07 25.08 25.09 25.10 25.11 25.12 25.13 25.14 25.15 25.16 25.17 25.18 25.19 25.20 25.21 25.22 25.23 25.24 25.25 25.26 25.27 25.28 25.29 25.30 25.31 25.32 25.33 25.34 25.35 25.36 25.37 25.38 25.39 25.40 25.41 25.42 25.43 25.44 25.45 25.46 25.47 25.48 25.49 25.50 25.51 A reference set of clinically relevant adverse drug-drug interactions, hypothetically
  26. 26.0 26.1 A reference set of clinically relevant adverse drug-drug interactions, yn ôl pob tebyg